Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence.

Hematology. American Society of Hematology. Education Program - 1 Jan 2013

van Besien Koen

Abstract excerpt

Allogeneic transplantation constitutes curative treatment for acute myeloid leukemia and myelodysplastic syndrome. Its therapeutic effects are to a large extent mediated by GVL effects, but partially offset by treatment-related mortality and loss of quality of life caused by acute and chronic GVHD. Although severe acute and chronic GVHD are associated with a reduction in relapse risk, they are not associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to Cord Blood Stem Cell Transplantation
Share to Donor Selection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft vs Host Disease

Share to HLA-DP Antigens

Share to Leukemia, Myeloid, Acute

Share to Lymphocyte Depletion

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 24319163
DOI: 10.1182/asheducation-2013.1.56

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence.PMID 24319163Read ↗

Cord blood chimerism and relapse after haplo-cord transplantation.Semantic proximity Read ↗

Donor KIR Genotype Impacts on Clinical Outcome after T Cell-Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients.Semantic proximity Read ↗

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.Semantic proximity Read ↗

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.Semantic proximity Read ↗

Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.Semantic proximity Read ↗

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.Semantic proximity Read ↗

New directions in the genomics of allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.Semantic proximity Read ↗

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.Semantic proximity Read ↗

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.Semantic proximity Read ↗

Acute GvHD: pathogenesis and classification.Semantic proximity Read ↗

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.